skip to content

Cambridge Stem Cell Institute

 

Strategic Advisory Committee

The SAC supports the Director and Deputy Director with expert evaluation & advice. It formulates, implements and ensures effective delivery of the Institute key strategic objectives. The committee is made up of all professorial members of the Institute as well as full PI, affiliated PI and professional support reps.

Bertie Gottgens

Professor Bertie Göttgens (Chair) 

Professor Sarah Bray

Danielle Daft

Danielle Daft

Steph Hall

Brian Huntly

Professor Brian Huntly 

Professor Walid Khaled

Professor Walid Khaled

Madeline Lancaster

Professor Madeline Lancaster

Elisa Laurenti

Professor Elisa Laurenti

Sanjay Sinha headshot

Professor Sanjay Sinha

Anthea Stanley

Anthea Stanley

Mekayla Storer

Dr Mekayla Storer

Sarah Teichmann

Professor Sarah Teichmann

Richard Tyser

Dr Richard Tyser 

 

 

 

 


 International Scientific Advisory Board

The ISAB consists of distinguished stem cell researchers who provide expert evaluation and advice through annual visits and reports

Cedric Blanpain

Prof Cedric Blanpain
Epithelial stem cells and cancer 
Professor and Director of the Laboratory of Stem cells and Cancer, Université libre de Bruxelles

Cristina Lo Celso

Prof Cristina Lo Celso
Bone marrow microenvironment, healthy and malignant haematopoietic stem cell niches, leukaemia 
Professor of stem cell biology, Department of Life Sciences, Co-director, Centre for Haematology, Imperial College London

Samantha Morris

Prof Samantha Morris
Associate Professor of Genetics and Developmental Biology, Washington University School of Medicine

Lim Chee Teck

Dr Chwee Teck Lim 
Cellular Mechanobiology, Microfluidics
NUSS Chair Professor and Director, Institute for Health Innovation and Technology, National University of Singapore

Timm Schroeder

Prof Timm Schroeder
Molecular stem cell fate control
Professor, Department of Biosystems Science and Engineering, Swiss Federal Institute of Technology Zurich (ETHZ), Basel, Switzerland

Dave Michalovich

Dr Dave Michalovich
GlaxoSmithKline